Position in VNDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,405,890
+$10,325,183 QoQ
Shares Held
3,497,695
+118.1% QoQ
Ownership
5.78%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#3
of 172 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,647,082,398 across 216 Biotechnology names. VNDA ranks #27 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in VNDA
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,405,893 | 3,497,695 | Shares | Sole | 2026-08-13 | |
| 2026-06-30 | $21,405,890 | 3,497,695 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $11,080,707 | 1,603,576 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $5,530,190 | 627,006 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $3,335,643 | 668,466 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $640,616 | 135,724 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $236,658 | 51,560 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $239,398 | 49,979 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $309,178 | 65,923 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $428,772 | 75,889 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $110,739 | 26,944 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $68,553 | 16,245 | Shares | Defined | 2024-02-14 | |
| 2021-06-30 ALXN | — | 238,357 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 ALXN | — | 267,194 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 ALXN | — | 378,239 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 ALXN | — | 1,884,423 | Shares | Other | 2020-11-16 | |
| 2020-06-30 ALXN | — | 2,107,434 | Shares | Other | 2020-08-17 | |
| 2020-03-31 ALXN | — | 2,729,332 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||